Aims/Introduction The combination therapy of dipeptidyl\peptidase (DPP)\4 inhibitor and \glucosidase inhibitors (\GIs) is impressive in suppressing postprandial hyperglycemia. and voglibose, and dual therapy of alogliptin and miglitol). The principal result measure was SD between \GIs. Outcomes SD was considerably improved with the addition of either voglibose (18.9??10.1) or miglitol (19.6??8.2) to alogliptin monotherapy (36.2??8.7). MAGE… Continue reading Aims/Introduction The combination therapy of dipeptidyl\peptidase (DPP)\4 inhibitor and \glucosidase inhibitors